{"id":"https://openalex.org/W7223032002","doi":"https://doi.org/10.3389/fimmu.2026.2020350","title":"Editorial: Liver diseases \u2013 from pathophysiology to new treatment options","display_name":"Editorial: Liver diseases \u2013 from pathophysiology to new treatment options","publication_year":2026,"publication_date":"2026-10-20","ids":{"openalex":"https://openalex.org/W7223032002","doi":"https://doi.org/10.3389/fimmu.2026.2020350","pmid":"https://pubmed.ncbi.nlm.nih.gov/42978668","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13727581"},"language":"en","primary_location":{"id":"doi:10.3389/fimmu.2026.2020350","doi":"https://doi.org/10.3389/fimmu.2026.2020350","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.2020350","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.2020350/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"volume":null,"type":"editorial","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.2020350/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016738968","display_name":"\u0398\u03b5\u03cc\u03b4\u03c9\u03c1\u03bf\u03c2 \u0391\u03bd\u03b4\u03c1\u03bf\u03c5\u03c4\u03c3\u03ac\u03ba\u03bf\u03c2","orcid":"https://orcid.org/0000-0003-2556-6230","observed_orcids":["https://orcid.org/0000-0003-2556-6230"]},"institutions":[{"id":"https://openalex.org/I200777214","display_name":"National and Kapodistrian University of Athens","ror":"https://ror.org/04gnjpq42","country_code":"GR","type":"education","lineage":["https://openalex.org/I200777214"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"Theodoros Androutsakos","raw_affiliation_strings":["Department of Pathophysiology, Medical School, National and Kapodistrian University of Athens"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathophysiology, Medical School, National and Kapodistrian University of Athens","institution_ids":["https://openalex.org/I200777214"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019722292","display_name":"Narjes Nasiri Ansari","orcid":"https://orcid.org/0000-0002-0116-693X","observed_orcids":["https://orcid.org/0000-0002-0116-693X"]},"institutions":[{"id":"https://openalex.org/I44260953","display_name":"Heinrich Heine University D\u00fcsseldorf","ror":"https://ror.org/024z2rq82","country_code":"DE","type":"education","lineage":["https://openalex.org/I44260953"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Narjes Nasiri-Ansari","raw_affiliation_strings":["Division of Cardiology, Pulmonology, and Vascular Medicine, University Hospital and Medical Faculty, Heinrich Heine University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Cardiology, Pulmonology, and Vascular Medicine, University Hospital and Medical Faculty, Heinrich Heine University","institution_ids":["https://openalex.org/I44260953"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078249977","display_name":"\u039cargarita Papatheodoridi","orcid":"https://orcid.org/0000-0001-8581-6591","observed_orcids":["https://orcid.org/0000-0001-8581-6591"]},"institutions":[{"id":"https://openalex.org/I200777214","display_name":"National and Kapodistrian University of Athens","ror":"https://ror.org/04gnjpq42","country_code":"GR","type":"education","lineage":["https://openalex.org/I200777214"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"Margarita Papatheodoridi","raw_affiliation_strings":["Academic Department of Gastroenterology, Medical School of National and Kapodistrian University of Athens"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Academic Department of Gastroenterology, Medical School of National and Kapodistrian University of Athens","institution_ids":["https://openalex.org/I200777214"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036126963","display_name":"Dimitrios S. Karagiannakis","orcid":"https://orcid.org/0000-0003-0082-634X","observed_orcids":["https://orcid.org/0000-0003-0082-634X"]},"institutions":[{"id":"https://openalex.org/I200777214","display_name":"National and Kapodistrian University of Athens","ror":"https://ror.org/04gnjpq42","country_code":"GR","type":"education","lineage":["https://openalex.org/I200777214"]}],"countries":["GR"],"is_corresponding":true,"raw_author_name":"Dimitrios Karagiannakis","raw_affiliation_strings":["Fourth Department of Internal Medicine, \u201cAttikon\u201d University Hospital, School of Medicine, National and Kapodistrian University of Athens"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fourth Department of Internal Medicine, \u201cAttikon\u201d University Hospital, School of Medicine, National and Kapodistrian University of Athens","institution_ids":["https://openalex.org/I200777214"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5036126963"],"corresponding_institution_ids":["https://openalex.org/I200777214"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":null,"first_page":"2020350","last_page":"2020350"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10340","display_name":"Hepatitis B Virus Studies","score":0.38089999556541443,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10340","display_name":"Hepatitis B Virus Studies","score":0.38089999556541443,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10966","display_name":"Liver physiology and pathology","score":0.27250000834465027,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10351","display_name":"Liver Disease Diagnosis and Treatment","score":0.0940999984741211,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/liver-disease","display_name":"liver disease","score":0.9559999704360962},{"id":"https://openalex.org/keywords/chronic-hepatitis-b","display_name":"chronic hepatitis B","score":0.9020000100135803},{"id":"https://openalex.org/keywords/hepatitis-c","display_name":"hepatitis C","score":0.9210000038146973},{"id":"https://openalex.org/keywords/viral-hepatitis","display_name":"viral hepatitis","score":0.5920000076293945},{"id":"https://openalex.org/keywords/pattern-recognition-receptors","display_name":"pattern recognition receptors","score":0.8859999775886536},{"id":"https://openalex.org/keywords/toll-like-receptors","display_name":"Toll-like receptors","score":0.8939999938011169},{"id":"https://openalex.org/keywords/rig-i-like-receptors","display_name":"RIG-I-like receptors","score":0.9290000200271606},{"id":"https://openalex.org/keywords/innate-immunity","display_name":"innate immunity","score":0.6610000133514404},{"id":"https://openalex.org/keywords/mbd2","display_name":"MBD2","score":0.9660000205039978},{"id":"https://openalex.org/keywords/hla-dr-expression","display_name":"HLA-DR expression","score":0.5220000147819519},{"id":"https://openalex.org/keywords/hla-dr2","display_name":"HLA-DR2","score":0.3330000042915344},{"id":"https://openalex.org/keywords/hla-dr3","display_name":"HLA-DR3","score":0.5019999742507935},{"id":"https://openalex.org/keywords/hla-dr4","display_name":"HLA-DR4","score":0.597000002861023},{"id":"https://openalex.org/keywords/hla-dr5","display_name":"HLA-DR5","score":0.7390000224113464},{"id":"https://openalex.org/keywords/hla-dr6","display_name":"HLA-DRw6","score":0.5289999842643738}],"concepts":[{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.6140000224113464},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.6104999780654907},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5078999996185303},{"id":"https://openalex.org/C136449434","wikidata":"https://www.wikidata.org/wiki/Q428253","display_name":"Innate immune system","level":3,"score":0.5024999976158142},{"id":"https://openalex.org/C120197328","wikidata":"https://www.wikidata.org/wiki/Q2838685","display_name":"Retinoic acid receptor","level":4,"score":0.4401000142097473},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4302000105381012},{"id":"https://openalex.org/C2777075537","wikidata":"https://www.wikidata.org/wiki/Q929737","display_name":"Liver disease","level":2,"score":0.42579999566078186},{"id":"https://openalex.org/C2777382497","wikidata":"https://www.wikidata.org/wiki/Q6853","display_name":"Hepatitis B","level":2,"score":0.41850000619888306},{"id":"https://openalex.org/C2777072776","wikidata":"https://www.wikidata.org/wiki/Q1983841","display_name":"Viral hepatitis","level":2,"score":0.41359999775886536},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.4018000066280365},{"id":"https://openalex.org/C2776029263","wikidata":"https://www.wikidata.org/wiki/Q131742","display_name":"Hepatitis","level":2,"score":0.3824000060558319},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.36329999566078186},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3546999990940094},{"id":"https://openalex.org/C2776455275","wikidata":"https://www.wikidata.org/wiki/Q154869","display_name":"Hepatitis C","level":2,"score":0.3424000144004822},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3278999924659729},{"id":"https://openalex.org/C41091548","wikidata":"https://www.wikidata.org/wiki/Q26939","display_name":"Epigenetics","level":3,"score":0.3142000138759613},{"id":"https://openalex.org/C143121216","wikidata":"https://www.wikidata.org/wiki/Q1330402","display_name":"Microbiome","level":2,"score":0.30550000071525574},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.29420000314712524},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.29019999504089355},{"id":"https://openalex.org/C2780593183","wikidata":"https://www.wikidata.org/wiki/Q6844","display_name":"Hepatitis B virus","level":3,"score":0.2777000069618225},{"id":"https://openalex.org/C163763905","wikidata":"https://www.wikidata.org/wiki/Q17075943","display_name":"Precision medicine","level":2,"score":0.2745000123977661},{"id":"https://openalex.org/C89611455","wikidata":"https://www.wikidata.org/wiki/Q6804646","display_name":"Mechanism (biology)","level":2,"score":0.2743000090122223},{"id":"https://openalex.org/C2781121885","wikidata":"https://www.wikidata.org/wiki/Q425517","display_name":"Retinoic acid","level":3,"score":0.2667999863624573}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fimmu.2026.2020350","doi":"https://doi.org/10.3389/fimmu.2026.2020350","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.2020350","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.2020350/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13727581","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13727581/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13727581/pdf/fimmu-17-2020350.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Immunol","raw_type":"Text"},{"id":"pmid:42978668","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42978668","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in immunology","raw_type":"Editorial"},{"id":"pmh:oai:doaj.org/article:4a9256bfc6684e4380845a164c73613d","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/4a9256bfc6684e4380845a164c73613d","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Immunology, Vol 17 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fimmu.2026.2020350","doi":"https://doi.org/10.3389/fimmu.2026.2020350","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.2020350","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.2020350/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7223032002.pdf","grobid_xml":"https://content.openalex.org/works/W7223032002.grobid-xml"},"referenced_works_count":25,"referenced_works":["https://openalex.org/W2032627193","https://openalex.org/W2745107259","https://openalex.org/W2896861389","https://openalex.org/W3095484986","https://openalex.org/W3164404165","https://openalex.org/W3207898463","https://openalex.org/W4200029854","https://openalex.org/W4210774372","https://openalex.org/W4306759100","https://openalex.org/W4311566367","https://openalex.org/W4362670532","https://openalex.org/W4367553951","https://openalex.org/W4387519986","https://openalex.org/W4390060217","https://openalex.org/W4391848166","https://openalex.org/W4393159060","https://openalex.org/W4401712318","https://openalex.org/W4404486554","https://openalex.org/W4405529078","https://openalex.org/W4410219383","https://openalex.org/W4412877886","https://openalex.org/W4415873147","https://openalex.org/W4415927728","https://openalex.org/W7126212233","https://openalex.org/W7160755422"],"related_works":["https://openalex.org/W4391144098","https://openalex.org/W4389297278","https://openalex.org/W2066833659","https://openalex.org/W4210401741","https://openalex.org/W3148282282","https://openalex.org/W7213557630","https://openalex.org/W2071267501","https://openalex.org/W7212191624","https://openalex.org/W2145018004","https://openalex.org/W2048797482"],"abstract_inverted_index":{"Liver":[0,2127],"diseases":[1,1104,1822,1964,2262],"are":[2,34,566,575,1551,1858],"a":[3,95,152,363,386,448,463,472,502,820,843,915,939,975,1057,1107,1128,1194,1251,1304,1376,1453,1464,1581,1628,1693,1839,1983,2021,2039,2107,2192],"major":[4,96,123,333,940,1694,1944,1984,2058],"global":[5,943],"health":[6],"challenge,":[7],"spanning":[8],"viral,":[9,2380],"autoimmune,":[10,2381],"cholestatic,":[11,2382],"metabolic,":[12,1946,2383],"and":[13,21,31,41,46,59,66,73,84,91,101,131,145,169,184,200,229,260,306,318,326,355,366,412,425,437,475,498,529,548,564,571,574,581,589,594,639,682,707,712,721,730,737,753,778,793,813,827,870,884,899,901,945,1047,1064,1068,1088,1122,1148,1169,1190,1208,1228,1281,1284,1344,1366,1392,1397,1414,1474,1488,1508,1528,1548,1559,1576,1593,1595,1601,1612,1617,1645,1656,1703,1720,1750,1765,1777,1783,1807,1812,1833,1865,1873,1878,1897,1907,1928,1943,1947,1965,2015,2050,2073,2083,2135,2155,2165,2182,2202,2226,2245,2256,2263,2277,2298,2308,2315,2319,2331,2333,2352,2356,2376,2384,2394,2398,2409,2421,2434,2441],"alcohol-associated":[14,2385],"diseases,":[15,1165],"with":[16,103,111,194,214,277,297,301,377,439,510,578,685,719,734,746,831,926,999,1002,1023,1127,1256,1268,1295,1301,1467,1563,1599,1621,1643,1654,1773,2064,2117,2177,2335,2444],"progression":[17,40],"to":[18,88,143,218,263,332,351,494,651,661,671,699,865,907,953,1044,1095,1327,1382,1388,1499,1606,1732,1797,1846,1952,1979,2034,2093,2151,2210,2224,2265,2271,2349,2415,2428,2436,2450],"cirrhosis,":[19,495,1001,1592,1938,2416],"decompensation,":[20,497,2419],"hepatocellular":[22,499,908,1577,1698,1722],"carcinoma":[23],"(HCC).":[24],"Advances":[25],"in":[26,51,125,140,294,323,348,373,394,481,508,535,555,568,597,613,659,690,717,783,804,862,890,957,997,1025,1137,1248,1293,1316,1352,1463,1539,1627,1663,1810,1937,1987,2097,2179,2291],"molecular":[27,595,1904,1959,2440],"biology,":[28],"genetics,":[29],"immunology,":[30],"systems":[32,2279],"biology":[33,2092],"refining":[35],"our":[36,1860],"understanding":[37,1138,1861],"of":[38,98,269,275,313,320,398,466,487,505,525,531,603,636,677,765,780,847,851,893,942,961,964,969,990,1008,1015,1066,1110,1163,1246,1253,1264,1307,1314,1331,1379,1399,1456,1494,1511,1536,1543,1555,1566,1584,1676,1687,1696,1712,1737,1793,1805,1823,1862,1931,1961,1969,1991,1998,2023,2060,2109,2248,2287],"disease":[39,302,1145,1233,1317,1430,1435,1558,1603,1850,1994,2100,2351,2373],"informing":[42],"new":[43],"diagnostic,":[44],"prognostic,":[45],"therapeutic":[47,367,476,708,1359,1818,1908,2361,2377,2432],"strategies.":[48,175],"This":[49],"Frontiers":[50],"Immunology":[52],"Research":[53,653,1608,1954,2212,2366],"Topic":[54,654,1609,1955,2213,2367],"brought":[55],"together":[56],"basic,":[57],"translational,":[58],"clinical":[60,160,307,977,1353,1611,2445],"studies":[61,78,309],"focused":[62,1158],"on":[63,197,608,834,1005,1159,1760,1827,2076,2401],"inflammation,":[64,305,1573,1715,1828,2012,2045,2402],"metabolic":[65,1602,1613,1718,1898],"immune":[67,165,249,255,356,371,379,569,583,897,927,1019,1176,1200,1412,1530,1574,1615,1716,1893,1948,2046,2095,2204,2243,2257,2329,2370,2403],"dysregulation,":[68,1575,1717,1894,2404],"fibrogenesis,":[69],"biomarkers,":[70,810,1906,2431],"non-invasive":[71],"approaches,":[72,427,1224],"emerging":[74,1222,1367,1406,2285],"therapies.":[75],"Collectively,":[76],"these":[77,215,657,769,1164,2452],"highlight":[79],"both":[80,1709,1924,1957],"shared":[81],"biological":[82],"pathways":[83,238,330,573,1092,1210],"disease-specific":[85,1844],"mechanisms":[86,217,777,800,902,1081,1142,1562,1711],"relevant":[87,450],"precision":[89,1223],"diagnosis":[90,1493,1510,1542,1960],"treatment.Viral":[92],"hepatitis":[93,113,117,400,512,701,1116],"remains":[94,628,938,1692,2187],"cause":[97,941,1583,1695],"liver-related":[99,1308],"morbidity":[100,944],"mortality,":[102],"more":[104,958,1423,1639],"than":[105,959],"300":[106],"million":[107],"people":[108],"worldwide":[109,1131],"living":[110],"chronic":[112,399,482,511,784,854,904,1111,1556,1585,1697,1848,1992,2061,2098,2221],"B":[114,513,702],"(HBV)":[115],"or":[116,2002],"C":[118],"(HCV)":[119],"infection":[120,150,172,484,605,906],"[1][2][3][4].":[121],"Despite":[122,1134,2388],"advances":[124,1136,2453],"HBV":[126,212,414,483,604,785,855,867,905],"vaccination,":[127],"long-term":[128,506],"antiviral":[129,934],"suppression,":[130],"highly":[132,931],"effective":[133,932],"curative":[134],"therapy":[135],"for":[136,242,369,478,633,824,853,1231,1291,1370,1681,1816,2196],"HCV,":[137],"substantial":[138,1135,1377],"gaps":[139],"diagnosis,":[141],"linkage":[142],"care,":[144],"treatment":[146,602,637,950,1368,1426,2074,2180,2437],"coverage":[147],"persist":[148],"globally.HBV":[149],"follows":[151],"complex,":[153],"dynamic":[154],"natural":[155,1989],"history":[156,1990],"characterized":[157,251,1178,2041],"by":[158,163,252,403,1061,1179,1746,1940,2042],"overlapping":[159],"phases":[161],"shaped":[162],"host":[164,230,2203],"response,":[166],"viral":[167,192,227,894,924,1870,2391],"replication,":[168],"age":[170],"at":[171,389,727,741,1684,1971],"[5].HBV":[173],"evasion":[174],"They":[176,857],"summarized":[177],"how":[178,211,1855,2304,2344],"pattern-recognition":[179,236],"receptors":[180,199],"sense":[181],"HBVderived":[182],"DNA":[183],"RNA,":[185,188],"including":[186,329,1114,1225,1266,1334,1869,2121],"pregenomic":[187],"as":[189,191,239,291,362,447,462,471,550,591,624,697,762,875,1289,1346,1348,1570,1885,2359],"well":[190,1347,1498],"proteins,":[193],"particular":[195,832,1003],"emphasis":[196,833,1004],"Toll-like":[198],"retinoic":[201],"acid-inducible":[202],"gene":[203,421],"I":[204],"(RIG-I)-like":[205],"pathways.":[206],"The":[207,283,358,787,816,1172,1218,1372,1501,1660,1791,1975,1996,2138],"authors":[208,284,359,429,545,788,1373,1502,2302],"further":[209,560,1671,1801,2029],"discussed":[210,858],"interferes":[213],"sensing":[216],"establish":[219],"persistent":[220,991,1196],"infection.":[221,786,856],"By":[222,416],"delineating":[223],"the":[224,267,395,428,440,523,544,631,776,790,798,805,848,859,871,876,880,891,911,930,967,987,1006,1026,1079,1141,1160,1167,1202,1244,1312,1328,1335,1356,1394,1419,1439,1445,1492,1505,1519,1522,1534,1540,1673,1803,1918,1925,1929,1958,1966,1972,1988,2067,2094,2141,2147,2217,2235,2238,2272,2284,2288,2301,2354],"interplay":[225,2274],"between":[226,1525,2275],"components":[228],"innate":[231,254],"immunity,":[232],"this":[233,516,652,1012,1512,1607,1953,2031,2189,2211,2249,2365],"review":[234,817,1157,1219,1405],"highlights":[235,1221,1521,1881,2353],"receptor":[237,1340,1758,1780],"potential":[240,364,473,592,760,1523,1674,1734,1814,2360],"targets":[241,596,1815,1909,2362],"future":[243,1817],"immunomodulatory":[244],"approaches":[245,864,1901,2435],"[6].Immune":[246],"dysfunction,":[247,1181,2014,2047],"namely":[248,1166],"paralysis,":[250],"impaired":[253,352,1038],"responses,":[256,328,380],"compromised":[257],"antimicrobial":[258],"defense,":[259],"increased":[261,315,716,1685,1774],"susceptibility":[262],"secondary":[264],"infections,":[265],"was":[266,744,1042,1260],"focus":[268],"Xiaoqin":[270],"Liu":[271],"et":[272,383,520,665,773,840,984,1241,1362,1450,1725,1852,2281],"al.'s":[273],"study":[274,1014,1252,2190],"patients":[276,509,718,998,1035,1055,1255,1294,1300,1380,1642,1683],"HBV-related":[278,536,556],"acuteon-chronic":[279],"liver":[280,488,599,1103,1213,1446,1557,1567,1586,1821,1849,1993,2036,2062,2079,2099,2200,2222,2261,2293,2350,2386],"failure":[281,2037],"(HBV-ACLF).":[282],"identified":[285,430,546,1753],"Methyl-CpG-binding":[286],"domain":[287],"protein":[288,684],"2":[289,688,1763],"(MBD2)":[290],"significantly":[292],"upregulated":[293],"HBV-ACLF":[295],"monocytes,":[296,349],"expression":[298,347,676,725],"levels":[299,715,726],"correlating":[300],"severity,":[303],"systemic":[304,1045,2011,2044],"outcome.Mechanistic":[308],"showed":[310,1481],"that":[311,342,458,562,641,921,1076,1093,1143,1375,1436,1842,1910,2369],"loss":[312],"MBD2":[314,343,361],"chromatin":[316],"accessibility":[317],"transcription":[319,532],"genes":[321,393,554],"involved":[322,567],"antigen":[324,353,704],"presentation":[325,354],"pro-inflammatory":[327,1182],"related":[331],"histocompatibility":[334],"complex":[335,1161,2006,2273],"(MHC)":[336],"class":[337],"II":[338],"synthesis.These":[339],"findings":[340,1074],"suggest":[341,1075],"epigenetically":[344],"represses":[345],"HLA-DR":[346],"leading":[350,877,1582,2033],"paralysis.":[357],"proposed":[360,2340],"biomarker":[365,474],"target":[368,477],"restoring":[370],"competence":[372],"ACLF.":[374],"[7]":[375],"Continuing":[376],"HBV-oriented":[378],"Fangfang":[381],"Li":[382],"al.":[384,521,666,774,841,985,1242,1363,1451,1726,1853,2282],"contributed":[385],"manuscript":[387],"aimed":[388],"identifying":[390,587,1682],"characteristic":[391,2162],"hub":[392,433],"immune-active":[396,441],"phase":[397],"B,":[401],"defined":[402,623],"positive":[404],"serum":[405,1275,1286,1476],"HBsAg,":[406],"elevated":[407,1278],"alanine":[408],"transaminase":[409],"(ALT)":[410],"levels,":[411],"detectable":[413],"DNA.":[415],"integrating":[417,2197],"transcriptomic":[418],"analyses,":[419,1752],"weighted":[420],"co-expression":[422],"network":[423],"analysis,":[424],"machine-learning":[426],"four":[431,1754],"candidate":[432,2430],"genes-CCR5,":[434],"IL10RA,":[435],"KCNA3,":[436],"SLC24A4associated":[438],"phase.":[442],"Among":[443],"these,":[444],"SLC24A4":[445,459,470],"emerged":[446,874,1288],"particularly":[449,1636],"immune-regulatory":[451],"candidate.":[452],"In":[453,1011,1034,1052,1250,1271,2020,2106],"silico":[454],"knockout":[455],"analyses":[456,559,886],"suggested":[457],"may":[460,1089,1211,1902,2028,2252,2311,2326,2347],"act":[461],"negative":[464],"regulator":[465],"monocyte":[467],"activation,":[468,1186,1832,1889],"highlighting":[469],"immune-modulatory":[479],"strategies":[480,640,920,1427],"[8].Progressive":[485],"development":[486,1354,1997],"fibrosis,":[489,1487,1591],"which":[490,1496,1770,1788],"can":[491,2413],"eventually":[492],"lead":[493,2414],"hepatic":[496,1027,1083,1459,1469,1545,1798,1829,1863,1886,2003,2017,2254,2276,2328],"carcinoma,":[500],"is":[501,1432,1580,1596,2056,2231],"key":[503,551,1561],"determinant":[504],"prognosis":[507],"[9].To":[514],"unravel":[515],"process,":[517],"Jiahao":[518],"Wu":[519],"investigated":[522,986],"role":[524,2286],"Janus":[526],"kinase-signal":[527],"transducer":[528],"activator":[530],"(JAK-STAT)":[533],"signaling":[534],"fibrogenic":[537],"progression.":[538,1318],"Using":[539],"an":[540,866,1384,1728],"integrated":[541,1729],"bioinformatics":[542],"approach,":[543],"CCND1":[547,563,588],"IL7R":[549,565,590],"JAK-STAT":[552],"pathway-associated":[553],"fibrosis.":[557],"Functional":[558],"indicated":[561],"regulatory":[570],"profibrotic":[572],"closely":[576,1597],"associated":[577,745,1022,1598,1653,1741,1772,2116],"M1":[579],"macrophages":[580],"other":[582,1564],"cell":[584,1831,1888],"subsets,":[585],"thereby":[586],"biomarkers":[593,698,764,1290,1527],"HBV-associated":[598],"fibrosis":[600,1689,1838,1864],"[10].Current":[601],"relies":[606],"primarily":[607],"potent":[609,923],"nucleos(t)ide":[610],"analogs":[611],"and,":[612,803],"selected":[614],"patients,":[615,962,1017,1265,2024,2111],"pegylated":[616],"interferon-\u03b1":[617],"(Peg-IFN-\u03b1);":[618],"however,":[619],"achieving":[620],"functional":[621],"cure,":[622],"sustained":[625],"HBsAg":[626,735,748],"loss,":[627],"uncommon,":[629],"underscoring":[630,1311],"need":[632],"reliable":[634],"predictors":[635],"response":[638,767,1387,2181,2378],"optimize":[642],"efficacy":[643],"while":[644,2086],"minimizing":[645],"treatment-related":[646],"toxicity":[647,782],"[11,12]":[648],"Two":[649],"contributions":[650,2209,2423],"specifically":[655],"addressed":[656],"issues":[658],"relation":[660],"Peg-IFN-\u03b1.":[662],"Hao":[663],"Pang":[664],"studied":[667],"91":[668],"HBV-infected":[669],"individuals":[670],"test":[672],"whether":[673],"early":[674,739,763],"ontreatment":[675],"ectonucleotide":[678],"pyrophosphatase/phosphodiesterase":[679],"1":[680,1781],"(ENPP1)":[681],"interferon-induced":[683],"tetratricopeptide":[686],"repeats":[687],"(IFIT2)":[689],"peripheral":[691],"blood":[692],"mononuclear":[693],"cells":[694,1800],"could":[695,2169],"serve":[696],"predict":[700],"surface":[703],"(HBsAg)":[705],"clearance":[706],"responses.":[709],"Both":[710],"ENPP1":[711,752],"IFIT2":[713,754],"mRNA":[714],"virological":[720,1100],"serological":[722],"responses;":[723],"their":[724,738,759,979,1139],"weeks":[728],"12":[729,743,1768],"24":[731],"positively":[732],"correlated":[733],"reduction,":[736],"induction":[740],"week":[742],"subsequent":[747],"decline.":[749],"Furthermore,":[750],"combining":[751],"improved":[755,2455],"predictive":[756,809],"performance,":[757],"supporting":[758],"utility":[761],"Peg-IFN-\u03b1":[766],"[13].Along":[768],"lines,":[770],"Liya":[771],"Zhu":[772],"reviewed":[775,1364,1854],"management":[779],"Peg-IFN\u03b1":[781],"describe":[789,2303],"most":[791],"common":[792,1882],"serious":[794],"adverse":[795,1309],"effects,":[796],"explain":[797],"pathophysiological":[799],"behind":[801],"each,":[802],"final":[806],"section,":[807],"discuss":[808,1393,1504],"risk":[811,836,1669,1686,2175],"prediction,":[812],"personalized":[814],"management.":[815],"therefore":[818],"provides":[819,2191],"clinically":[821,1622,2193],"oriented":[822,2194],"framework":[823,2195,2342],"anticipating,":[825],"monitoring,":[826],"managing":[828],"Peg-IFN-\u03b1-associated":[829],"toxicity,":[830],"individualized":[835],"assessment":[837,1538],"[14].Xingtao":[838],"Jin":[839],"provided":[842],"comprehensive":[844],"bibliometric":[845],"overview":[846],"evolving":[849,1358],"field":[850],"immunotherapy":[852],"growing":[860,888],"interest":[861,889,1325],"immune-based":[863,2087],"cure.":[868],"China":[869],"United":[872],"States":[873],"contributors.":[878],"At":[879,1917],"same":[881,1919],"time,":[882,1920],"keyword":[883],"citation":[885],"revealed":[887],"persistence":[892],"reservoirs,":[895],"profound":[896],"dysfunction":[898,1063,1547,1949,2307],"exhaustion,":[900],"linking":[903],"carcinoma.":[909],"Notably,":[910],"literature":[912],"landscape":[913],"indicates":[914],"clear":[916],"shift":[917,1421],"toward":[918,1422,2234],"combination":[919],"integrate":[922],"suppression":[925],"modulation":[928],"[15].Despite":[929],"direct-acting":[933],"(DAA)":[935],"treatment,":[936],"HCV":[937,955,995,1086],"mortality":[946,2053],"[2].":[947],"Although":[948,2184],"DAA":[949],"has":[951,1321],"led":[952],"successful":[954],"eradication":[956,1087],"95%":[960],"regardless":[963],"comorbidities":[965],"[16],":[966],"presence":[968],"cirrhosis":[970,1866,1970,1981,2065,2225],"and/or":[971],"portal":[972,992,1039,1097,2009,2081,2417],"hypertension":[973,993,1098],"poses":[974],"significant":[976,1324],"challenge.In":[978],"published":[980],"study,":[981],"Ruben":[982],"Martin-Escolano":[983],"immunological":[988,1080,2442],"determinants":[989],"after":[994,1085],"cure":[996,1101],"advanced":[1000,1688,1847],"impact":[1007],"HIV":[1009,1077],"coinfection.":[1010],"prospective":[1013],"41":[1016],"baseline":[1018,2113],"profiles":[1020],"were":[1021,1638,1651,1771,2115],"changes":[1024],"venous":[1028],"pressure":[1029,1040],"gradient":[1030],"over":[1031],"48":[1032],"weeks.":[1033],"without":[1036],"HIV,":[1037],"regression":[1041],"linked":[1043],"inflammation":[1046,1806,2255,2332],"broad":[1048],"CD4+":[1049,1070],"T-cell":[1050,1180],"activation.":[1051],"contrast,":[1053],"HIV-coinfected":[1054],"exhibited":[1056],"distinct":[1058,1175,1706,2174,2389],"profile":[1059],"marked":[1060,1939],"endothelial":[1062],"activation":[1065],"effector-memory":[1067],"TemRA":[1069],"T":[1071],"cells.":[1072],"These":[1073,1900,2324],"reshapes":[1078],"governing":[1082],"recovery":[1084],"help":[1090],"identify":[1091,2429],"contribute":[1094,2264,2348],"residual":[1096],"despite":[1099,1215],"[17].Autoimmune":[1102],"(AILDs)":[1105],"encompass":[1106],"heterogeneous":[1108],"group":[1109],"inflammatory":[1112,1209,1460,1472],"disorders,":[1113,2396],"autoimmune":[1115,1434,2393],"(AIH),":[1117],"primary":[1118,1123],"biliary":[1119,1203,1440],"cholangitis":[1120,1125],"(PBC),":[1121],"sclerosing":[1124],"(PSC),":[1126],"steadily":[1129],"rising":[1130],"prevalence":[1132,1306],"[18].":[1133],"immunopathogenesis,":[1140,1506],"drive":[1144],"initiation,":[1146,2374],"progression,":[1147,2375],"phenotypic":[1149],"heterogeneity":[1150],"remain":[1151],"incompletely":[1152],"understood":[1153],"[19][20][21].":[1154],"Zefeng":[1155],"Zhang's":[1156],"pathogenesis":[1162],"AIH-PBC":[1168],"AIH-PSC":[1170],"variants.":[1171],"author":[1173],"described":[1174],"architectures":[1177],"macrophage":[1183],"niches,":[1184],"B-cell":[1185],"tertiary":[1187],"lymphoid":[1188],"structures,":[1189],"senescent":[1191],"cholangiocytes.":[1192],"As":[1193],"result,":[1195],"crosstalk":[1197],"among":[1198,1641,2008,2237],"adaptive":[1199],"cells,":[1201],"epithelium,":[1204],"bile":[1205,1415,2317],"acid":[1206,1391,1416,2318,2322],"signaling,":[1207],"sustain":[1212],"injury":[1214,1699,1845,2223,2412],"conventional":[1216,1911,2218],"immunosuppression.":[1217],"also":[1220,1404,1503,2214],"JAK":[1226],"inhibition":[1227],"B-cell-depleting":[1229],"therapies,":[1230],"difficult-to-treat":[1232],"[22].To":[1234],"better":[1235],"understand":[1236],"AILD":[1237],"pathogenesis,":[1238],"Wenjuan":[1239],"Wang":[1240,1449],"examined":[1243,2283],"significance":[1245,1313],"ductopenia":[1247,1259,1292,1302,1315],"PBC.":[1249,1297,1371],"518":[1254],"biopsy-proven":[1257],"PBC,":[1258],"common,":[1261],"affecting":[1262],"56.76%":[1263],"24.83%":[1267],"early-stage":[1269,1296],"disease.":[1270],"multivariable":[1272],"logistic":[1273],"regression,":[1274],"ANA":[1276],"\u22651:1000,":[1277],"gamma-glutamyl":[1279],"transferase":[1280],"total":[1282],"bilirubin,":[1283],"low":[1285],"albumin":[1287],"During":[1298],"follow-up,":[1299],"had":[1303],"higher":[1305,1646,1667],"events,":[1310],"[23]":[1319],"PBC":[1320],"recently":[1322,1400],"attracted":[1323],"due":[1326],"rapid":[1329],"expansion":[1330],"second-line":[1332],"treatments,":[1333],"two":[1336],"approved":[1337],"peroxisome":[1338],"proliferator-activated":[1339],"(PPAR)":[1341],"agonists,":[1342],"elafibranor":[1343],"seladelpar,":[1345],"several":[1349,2112],"additional":[1350],"agents":[1351,1407],"[24].Against":[1355],"rapidly":[1357],"landscape,":[1360],"Angelara":[1361],"current":[1365],"options":[1369],"emphasize":[1374],"proportion":[1378],"fail":[1381],"achieve":[1383],"adequate":[1385],"biochemical":[1386],"first-line":[1389,2104],"ursodeoxycholic":[1390],"efficacy,":[1395],"safety,":[1396],"positioning":[1398],"introduced":[1401],"PPAR":[1402],"agonists.They":[1403],"targeting":[1408],"FXR,":[1409],"FGF19/FGFR4,":[1410],"NOX1/4,":[1411],"pathways,":[1413,1905],"transport,":[1417],"illustrating":[1418],"ongoing":[1420],"individualized,":[1424],"mechanism-based":[1425],"[25].Immunoglobulin":[1428],"G4-related":[1429],"(IgG4-RD)":[1431],"another":[1433,2057,2269],"commonly":[1437],"affects":[1438],"tract":[1441],"but":[1442],"usually":[1443],"spares":[1444],"[26].":[1447],"Wei":[1448],"reported":[1452],"rare":[1454,1513,1962],"case":[1455,1520],"seronegative,":[1457],"IgG4-related":[1458],"pseudotumor":[1461],"(IgG4-HIPT)":[1462],"60-year-old":[1465],"man":[1466],"multifocal":[1468],"lesions,":[1470],"mild":[1471],"symptoms,":[1473],"normal":[1475],"IgG4":[1477],"levels.":[1478],"Histopathological":[1479],"analysis":[1480,2164],"dense":[1482],"IgG4-positive":[1483],"lymphoplasmacytic":[1484],"infiltration,":[1485],"storiform":[1486],"obliterative":[1489],"phlebitis,":[1490],"establishing":[1491],"IgG4-HIPT,":[1495],"responded":[1497],"corticosteroids.":[1500],"significance,":[1507],"differential":[1509,1541],"entity":[1514],"[27].":[1515],"Beyond":[1516],"its":[1517,2227],"rarity,":[1518],"dissociation":[1524],"circulating":[1526],"tissue-level":[1529],"activity.":[1531],"It":[1532],"underscores":[1533],"importance":[1535,1804],"histological":[1537],"atypical":[1544],"lesions.Metabolic":[1546],"alcohol":[1549],"exposure":[1550],"increasingly":[1552,2089],"important":[1553],"drivers":[1554],"share":[1560,1710],"forms":[1565],"injury,":[1568,2408],"such":[1569,1884],"oxidative":[1571,1713,1895,2405],"stress,":[1572,1714,1896,2406],"damage":[1578,1723],"[28,29].MASLD":[1579],"disease,":[1587,2063],"encompassing":[1588],"steatosis,":[1589],"steatohepatitis,":[1590],"HCC,":[1594],"cardiovascular":[1600],"[29].":[1604],"Contributions":[1605,1951],"span":[1610],"markers,":[1614],"mechanisms,":[1616,1883],"experimental":[1618,1751,1932],"therapies.particularly":[1619],"those":[1620],"diagnosed":[1623],"non-alcoholic":[1624],"steatohepatitis":[1625],"(NASH),":[1626],"large":[1629],"case-control":[1630],"cohort":[1631,2108],"from":[1632,1739,1977,2220],"Qatar.":[1633],"Hematological":[1634],"abnormalities,":[1635],"thrombocytopenia,":[1637],"prevalent":[1640],"NASH,":[1644],"fibrosis-4":[1647],"(FIB-4)":[1648],"index":[1649],"values":[1650],"independently":[1652],"anemia":[1655],"abnormal":[1657],"platelet":[1658,1664],"counts.":[1659],"progressive":[1661,1721],"increase":[1662],"abnormalities":[1665],"across":[1666,1867,2259,2379],"FIB-4":[1668],"categories":[1670],"supports":[1672,1802],"value":[1675,1927],"readily":[1677,1915],"available":[1678],"hematological":[1679],"parameters":[1680,2145],"[30].":[1690],"Alcohol":[1691],"[35].":[1700],"However,":[1701],"MASLD":[1702],"ALD":[1704,1738,1775,1811,2399],"have":[1705],"initiating":[1707],"factors;":[1708],"alterations,":[1719],"[36].Zhou":[1724],"used":[1727],"multi-omics":[1730,1856],"strategy":[1731],"distinguish":[1733],"causal":[1735],"mediators":[1736],"merely":[1740],"biomarkers.":[1742],"Mendelian":[1743],"randomization,":[1744],"followed":[1745],"genetic,":[1747],"single-cell":[1748],"transcriptomic,":[1749,1876,2296],"compelling":[1755],"proteins:":[1756],"triggering":[1757],"expressed":[1759],"myeloid":[1761,1799],"cells-like":[1762],"(TREML2)":[1764],"matrix":[1766,1808,1835,1891],"metallopeptidase":[1767],"(MMP12),":[1769],"risk,":[1776],"phospholipase":[1778],"A2":[1779],"(PLA2R1)":[1782],"MYC-associated":[1784],"factor":[1785],"X":[1786],"(MAX),":[1787],"appeared":[1789],"protective.":[1790],"localization":[1792],"risk-associated":[1794],"proteins":[1795],"predominantly":[1796],"remodeling":[1809],"identifies":[1813],"investigation":[1819],"[37].Chronic":[1820],"diverse":[1824],"etiologies":[1825],"converge":[1826,2400],"stellate":[1830,1887],"extracellular":[1834,1890],"accumulation,":[1836],"making":[1837],"central":[1840],"process":[1841],"links":[1843,2372],"[38].Lu":[1851],"technologies":[1857],"reshaping":[1859],"etiologies,":[1868,2390],"hepatitis,":[1871,2392],"ALD,":[1872],"MASLD.":[1874],"Integrating":[1875,2439],"proteomic,":[1877,2297],"metabolomic":[1879,2299],"data":[1880],"deposition,":[1892],"alterations.":[1899],"uncover":[1903],"methods":[1912],"do":[1913],"not":[1914],"identify.":[1916],"cross-species":[1921],"comparisons":[1922],"underscore":[1923],"translational":[1926],"limitations":[1930],"models":[1933],"[39].Persistent":[1934],"fibrogenesis":[1935],"culminates":[1936],"architectural":[1941],"distortion":[1942],"vascular,":[1945],"[40].":[1950],"address":[1956],"inherited":[1963],"changing":[1967],"epidemiology":[1968],"population":[1973],"level.":[1974],"transition":[1976],"compensated":[1978],"decompensated":[1980],"represents":[1982],"turning":[1985],"point":[1986],"[43].":[1995],"ascites,":[1999],"variceal":[2000],"bleeding,":[2001],"encephalopathy":[2004],"reflects":[2005],"interactions":[2007,2236,2346],"hypertension,":[2010,2082,2418],"circulatory":[2013],"declining":[2016],"reserve":[2018],"[44].":[2019],"subset":[2022],"acute":[2025],"precipitating":[2026],"events":[2027],"destabilize":[2030],"balance,":[2032],"acute-on-chronic":[2035],"(ACLF),":[2038],"syndrome":[2040],"severe":[2043],"organ":[2048],"failure,":[2049],"high":[2051],"short-term":[2052],"[45].":[2054],"HCC":[2055,2102],"consequence":[2059],"remaining":[2066],"principal":[2068],"predisposing":[2069],"condition":[2070],"[47].":[2071],"Prognosis":[2072],"depend":[2075],"tumor":[2077,2091,2198],"burden,":[2078,2199],"function,":[2080,2201],"patient":[2084],"factors,":[2085],"therapies":[2088],"link":[2090],"environment":[2096],"[48].unresectable":[2101],"receiving":[2103],"immunotherapy.":[2105],"100":[2110],"characteristics":[2114,2205],"overall":[2118],"survival":[2119],"(OS),":[2120],"albuminbilirubin":[2122],"(ALBI)":[2123],"grade,":[2124],"Barcelona":[2125],"Clinic":[2126],"Cancer":[2128],"(BCLC)":[2129],"stage,":[2130],"macrovascular":[2131],"invasion,":[2132],"up-to-7":[2133],"criteria,":[2134],"lymphocyte":[2136],"infiltration.":[2137],"investigators":[2139],"incorporated":[2140],"strongest":[2142],"independent":[2143],"prognostic":[2144],"into":[2146,2173,2206,2454],"ALIVE-IO":[2148],"score,":[2149],"designed":[2150],"estimate":[2152],"1-year":[2153],"OS,":[2154],"internally":[2156],"validated":[2157],"it":[2158],"using":[2159],"receiver":[2160],"operating":[2161],"(ROC)":[2163],"10-fold":[2166],"cross-validation.":[2167],"Patients":[2168],"then":[2170],"be":[2171,2448],"stratified":[2172],"groups":[2176],"differences":[2178],"survival.":[2183],"external":[2185],"validation":[2186],"necessary,":[2188],"prognostication":[2207],"[49].The":[2208],"extend":[2215],"beyond":[2216,2425],"continuum":[2219],"complications.":[2228],"Increasing":[2229],"attention":[2230],"being":[2232],"directed":[2233],"intestinal":[2239,2241,2305,2357],"microbiome,":[2240],"barrier,":[2242],"system,":[2244],"liver.":[2246],"Disruption":[2247],"gut-liver":[2250,2289],"axis":[2251,2290],"influence":[2253],"responses":[2258],"multiple":[2260],"infectious":[2266],"complications,":[2267],"adding":[2268],"dimension":[2270],"extrahepatic":[2278],"[50].Bai":[2280],"invasive":[2292],"abscess.Integrating":[2294],"microbiomic,":[2295],"evidence,":[2300],"barrier":[2306,2358],"microbial":[2309],"dysbiosis":[2310],"facilitate":[2312],"bacterial":[2313,2336],"translocation":[2314],"alter":[2316],"short-chain":[2320],"fatty":[2321],"metabolism.":[2323],"processes":[2325],"promote":[2327],"dysregulation":[2330,2371],"interact":[2334],"virulence":[2337],"mechanisms.":[2338],"Their":[2339],"bacterium-inflammation-virulence":[2341],"illustrates":[2343],"host-microbial":[2345],"microbiota":[2355],"[51].Taken":[2363],"together,":[2364],"demonstrates":[2368],"diseases.":[2387],"cholestatic":[2395],"MASLD,":[2397],"cellular":[2407],"fibrogenesis.":[2410],"Persistent":[2411],"ACLF,":[2420],"hepatocarcinogenesis.Several":[2422],"go":[2424],"mechanistic":[2426],"descriptions":[2427],"targets,":[2433],"personalization.":[2438],"insights":[2443],"phenotyping":[2446],"will":[2447],"essential":[2449],"translating":[2451],"outcomes.":[2456]},"counts_by_year":[],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2026-10-21T00:00:00"}